Lisa Walter Analyst PerformanceVP Biotech Equity Research at Royal Bank Of CanadaLisa Walter is a stock analyst at Royal Bank Of Canada in the healthcare sector, covering 12 publicly traded companies. Over the past year, Lisa Walter has issued 43 stock ratings, including buy and hold recommendations. While full access to Lisa Walter's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Lisa Walter's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings46 Last 1 YearsBuy Recommendations89.13% 41 Buy RatingsCompanies Covered12 Unique Companies Ratings Distribution46RatingsDistribution of strong buy, buy, hold, and sell ratings by Lisa Walter.RatingPercentageCount Strong Buy0.0%0 ratings Buy89.1%41 ratings Hold10.9%5 ratings Sell0.0%0 ratingsOut of 46 total stock ratings issued by Lisa Walter at Royal Bank Of Canada, the majority (89.1%) have been Buy recommendations, followed by 10.9% Hold.Best & Worst CallsBest Call000.0%EYPTJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%VRDNAug 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ12 companiesLisa Walter, an analyst at Royal Bank Of Canada, currently covers 12 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare12 companies100.0%Lisa Walter of Royal Bank Of Canada specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY10 companies83.3%PHARMACEUTICALS2 companies16.7% Lisa Walter's Ratings History at Royal Bank Of Canada Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsEYPTEyepoint Pharmaceuticals8/18/2026Reiterated Rating$4.87$5.00Sector Perform$0.0000.00% ROIEYPTEyepoint Pharmaceuticals8/17/2026Downgrade$5.47$5.00Sector Perform$0.0000.00% ROIKRYSKrystal Biotech8/14/2026Initiated Coverage$328.34$400.00Outperform$0.0000.00% ROIMGTXMeiraGTx8/14/2026Boost Price Target$13.22$27.00Outperform$0.0000.00% ROIKRYSKrystal Biotech8/14/2026Initiated Coverage$332.27$400.00Outperform$0.0000.00% ROIVRDNViridian Therapeutics8/7/2026Boost Price Target$22.95$36.00Outperform$0.0000.00% ROIIRDOpus Genetics8/7/2026Lower Price Target$3.65$9.00Outperform$0.0000.00% ROIMIRMMirum Pharmaceuticals8/6/2026Lower Price Target$94.73$135.00Outperform$0.0000.00% ROIUTHRUnited Therapeutics8/6/2026Lower Price Target$527.58$677.00Outperform$0.0000.00% ROIRYTMRhythm Pharmaceuticals8/5/2026Boost Price Target$109.51$155.00Outperform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. MGTXMeiraGTx7/8/2026Boost Price Target$14.66$26.00Outperform$0.0000.00% ROIRYTMRhythm Pharmaceuticals7/7/2026Boost Price Target$111.68$141.00Outperform$0.0000.00% ROIMIRMMirum Pharmaceuticals7/7/2026Boost Price Target$121.91$148.00Outperform$0.0000.00% ROIUTHRUnited Therapeutics7/7/2026Boost Price Target$559.79$704.00Outperform$0.0000.00% ROIVRDNViridian Therapeutics6/30/2026Boost Price Target$18.79$35.00Outperform$0.0000.00% ROIMGTXMeiraGTx5/15/2026Boost Price Target$9.84$25.00Outperform$0.0000.00% ROIMIRMMirum Pharmaceuticals5/7/2026Boost Price Target$104.03$142.00Outperform$0.0000.00% ROIEYPTEyepoint Pharmaceuticals5/7/2026Lower Price Target$13.41$37.00Outperform$0.0000.00% ROIUTHRUnited Therapeutics5/7/2026Lower Price Target$574.57$701.00Outperform$0.0000.00% ROIMIRMMirum Pharmaceuticals5/7/2026Upgrade$106.17Moderate Buy$0.0000.00% ROIVRDNViridian Therapeutics5/6/2026Boost Price Target$18.77$34.00Outperform$0.0000.00% ROIRYTMRhythm Pharmaceuticals5/6/2026Boost Price Target$94.66$137.00Outperform$0.0000.00% ROIOCULOcular Therapeutix5/6/2026Reiterated Rating$9.70$30.00Outperform$0.0000.00% ROIMGTXMeiraGTx4/17/2026Boost Price Target$9.89$24.00Outperform$0.0000.00% ROIVRDNViridian Therapeutics4/7/2026Lower Price Target$13.90$30.00Outperform$0.0000.00% ROIFDMT4D Molecular Therapeutics3/19/2026Boost Price Target$8.73$35.00Outperform$0.0000.00% ROIRYTMRhythm Pharmaceuticals3/17/2026Lower Price Target$89.85$130.00Outperform$0.0000.00% ROIVRDNViridian Therapeutics2/27/2026Lower Price Target$28.41$42.00Outperform$0.0000.00% ROIUTHRUnited Therapeutics2/26/2026Boost Price Target$498.66$643.00Outperform$0.0000.00% ROIAPLSApellis Pharmaceuticals2/25/2026Lower Price Target$21.16$21.00Sector Perform$0.0000.00% ROIRYTMRhythm Pharmaceuticals2/18/2026Initiated Coverage$101.30$145.00Outperform$0.0000.00% ROIRYTMRhythm Pharmaceuticals2/18/2026Initiated Coverage$101.30$145.00Outperform$0.0000.00% ROIRYTMRhythm Pharmaceuticals2/18/2026Upgrade$99.76Moderate Buy$0.0000.00% ROIOCULOcular Therapeutix2/5/2026Reiterated Rating$9.29$30.00Outperform$0.0000.00% ROIFDMT4D Molecular Therapeutics1/7/2026Reiterated Rating$8.00Outperform$0.0000.00% ROIMGTXMeiraGTx11/14/2025Boost Price Target$8.26$16.00Outperform$0.0000.00% ROIFDMT4D Molecular Therapeutics11/11/2025Boost Price Target$10.50$32.00Outperform$0.0000.00% ROIEYPTEyepoint Pharmaceuticals11/6/2025Boost Price Target$11.51$39.00Outperform$0.0000.00% ROIVRDNViridian Therapeutics11/6/2025Boost Price Target$27.71$45.00Outperform$0.0000.00% ROIUTHRUnited Therapeutics10/30/2025Boost Price Target$450.38$587.00Outperform$0.0000.00% ROIThe retirement stock I'd buy before Nvidia today (Ad)In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.Get Marc Chaikin's free presentation on this overlooked AI stock nowADVMAdverum Biotechnologies10/28/2025Reiterated Rating$4.24$4.00Sector Perform$0.0000.00% ROIFDMT4D Molecular Therapeutics10/21/2025Reiterated Rating$10.85$26.00Outperform$0.0000.00% ROIUTHRUnited Therapeutics9/26/2025Initiated Coverage$425.42$569.00Outperform$0.0000.00% ROIVRDNViridian Therapeutics8/7/2025Lower Price Target$16.72$41.00Outperform$00.0000.00% ROIAPLSApellis Pharmaceuticals8/1/2025Boost Price Target$23.05$19.00Sector Perform$0.0000.00% ROIEYPTEyepoint Pharmaceuticals6/17/2025Initiated Coverage$8.90$28.00Outperform$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageCitigroupBarclaysMorgan StanleyBerenberg BankGuggenheimB. Riley FinancialShore Capital GroupCICC ResearchUBS GroupRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD Cowen Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
